| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 02/26/2009 | WO2009025149A1 Adnf receptor |
| 02/26/2009 | WO2009025091A1 Pharmaceutical composition for treatment of fibromyalgia |
| 02/26/2009 | WO2008084368A9 Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy |
| 02/26/2009 | US20090054495 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis |
| 02/26/2009 | US20090054459 Substituted indoles |
| 02/26/2009 | US20090054457 Substituted heterocyclic compounds |
| 02/26/2009 | US20090054446 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists |
| 02/26/2009 | US20090054424 Optically active pyridine derivative and a medicament containing the same |
| 02/26/2009 | US20090054397 Pyrazole compounds and pharmaceutical compositions comprising the compound |
| 02/26/2009 | US20090054302 Methods and Preparations For Curing Clinically Ill Patients |
| 02/26/2009 | US20090053805 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 02/26/2009 | DE202008000655U1 Zusammensetzung zur Behandlung von Beschwerden und Erkrankungen der Muskeln und der Gelenke Composition for the treatment of disorders and diseases of the muscles and joints |
| 02/25/2009 | EP2027872A1 Neurotoxic component of a botulinum toxin for treating a facial disease |
| 02/25/2009 | EP2026794A1 Xanthone derivative for the treatment of muscular disorders |
| 02/25/2009 | EP2026788A1 Therapeutic combination for painful medical conditions |
| 02/25/2009 | EP1143965B1 Carbocyclic potassium channel inhibitors |
| 02/25/2009 | CN101375160A Potentiation of apoptosis by monoclonal antibodies |
| 02/25/2009 | CN101374426A Use of soluble dietary fibres against muscle wasting |
| 02/24/2009 | US7495109 Nociceptin analogs |
| 02/24/2009 | US7494661 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 02/24/2009 | CA2469813C Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
| 02/24/2009 | CA2339913C Pharmaceutical formulations and method for making |
| 02/19/2009 | WO2009022687A1 Phenylacetic acid compound |
| 02/19/2009 | WO2009021747A2 Treatment of duchenne muscular dystrophy |
| 02/19/2009 | WO2008156513A3 Methods to protect skeletal muscle against injury |
| 02/19/2009 | US20090048314 Treatment of duchenne muscular dystrophy |
| 02/19/2009 | US20090048185 Therapeutic Drug for Suppressing Functions of NKT Cells Containing Glycolipid Derivative as Active Ingredient |
| 02/19/2009 | US20090047294 Inhibitors of prolyl-hydroxylase 1 for the treatment of skeletal muscle degeneration |
| 02/19/2009 | US20090047242 Conditioned blood composition and method for its production |
| 02/19/2009 | US20090047217 Polynucleotides Encoding Members of the Human B Lymphocyte Activation Antigen B7 Family and Polypeptides Encoded Thereby |
| 02/19/2009 | CA2695757A1 Phenylacetic acid compound |
| 02/19/2009 | CA2685605A1 Treatment of duchenne muscular dystrophy |
| 02/19/2009 | CA2685582A1 Treatment of duchenne muscular dystrophy |
| 02/18/2009 | EP2025666A2 Thiolalkyl benzoic acid derivatives |
| 02/18/2009 | EP2025346A1 Muscle regeneration promoter |
| 02/18/2009 | EP1569635B1 Use of carnitines for the prevention and/or treatment of disorders caused by the andropause |
| 02/18/2009 | EP1399431B1 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 02/18/2009 | EP1360178B1 Novel heterocyclic analogs of diphenylethylene compounds |
| 02/18/2009 | EP1028945B9 Substituted pyridine compounds as anti-inflammatory agents |
| 02/18/2009 | CN100462351C Amino acids with affinity for the alpha-2-delta-protein |
| 02/17/2009 | US7491047 Delivery of antihistamines through an inhalation route |
| 02/17/2009 | CA2518971C Composition for administration of iron for the treatment of restless legs syndrome |
| 02/12/2009 | WO2009019815A1 Novel γ-secretase inhibitor |
| 02/12/2009 | WO2009019505A2 Drug combinations for the treatment of duchenne muscular dystrophy |
| 02/12/2009 | WO2009019027A1 Use of 25-hydroxy vitamin d3 to increase muscle mass in mammals |
| 02/12/2009 | US20090042953 IMIDAZO [2,1,-b]-1,3,4-THIADIAZOLE SULFONAMIDES |
| 02/12/2009 | US20090042877 such as ethyl 6-oxo-7-phenyl-3-(pyridin-3-ylamino)-6,7-dihydrothieno [2,3-b]pyridine-2-carboxylate, potent and selective inhibitors of p38 MAP kinase and are of use in the prophylaxis and treatment of immune or inflammatory disorders |
| 02/12/2009 | US20090042270 Activatable recombinant neurotoxins |
| 02/12/2009 | US20090042199 Nucleotide sequences coding lymphocyte adhesion protein for use in treatment of autoimmunity, inflammation and infection |
| 02/12/2009 | CA2695877A1 Novel .gamma.-secretase inhibitor |
| 02/12/2009 | CA2685740A1 Drug combinations for the treatment of duchenne muscular dystrophy |
| 02/11/2009 | EP2021035A2 Cell-matrix microspheres, methods for preparation and applications |
| 02/11/2009 | EP2020999A1 Compositions comprising alpha-ketoglutarate and their use for modulating muscle performance |
| 02/11/2009 | EP1429800B1 Vaccine and use thereof for treatment of amyotrophic lateral sclerosis |
| 02/11/2009 | CN101362723A 2,4-diamino quinazolines compounds and synthesis method thereof |
| 02/11/2009 | CN100460414C Stable vitamin B6 derivative |
| 02/10/2009 | US7488738 Such as 4-({4-[[(4-Amino-2,3,5,6-tetramethylanilino)acetyl]-(methyl)amino]-1-piperidino}methyl)benzamide which has neuroprotective effects by inducing calcium binding proteins |
| 02/10/2009 | US7488710 Proteins containing the motif that are capable of binding to secreted Frizzled-related protein (Sfrp) family members |
| 02/10/2009 | CA2494506C Development of muscle mass in a mammal |
| 02/05/2009 | WO2009016326A2 Adeno-associated viral vectors for the expression of dysferlin |
| 02/05/2009 | WO2003099808A8 Substituted heterocyclic compounds and methods of use |
| 02/05/2009 | US20090035282 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
| 02/05/2009 | CA2697127A1 Adeno-associated viral vectors for the expression of dysferlin |
| 02/04/2009 | EP2019720A2 Treating muscular disorders and improving muscular function |
| 02/04/2009 | CN101360509A Composition containing several botulic toxins |
| 02/04/2009 | CN100457777C Leucine-based motif and clostridial neurotoxins |
| 02/04/2009 | CN100457735C Therapeutic agents useful for treating pain |
| 02/04/2009 | CN100457720C 2-propyl valeramide and 2-propyl pentaenuylamide derivative and application used as anti-convulsion medicine |
| 02/04/2009 | CN100457088C Pharmaceutical composition comprising lipids comprising polar and nonpolar moiety parts |
| 02/03/2009 | US7485730 Pharmaceutical compounds |
| 02/03/2009 | US7485669 Blockade of sodium channels by phenol derivatives |
| 02/03/2009 | US7485628 Inhibition of STAT-1 |
| 02/03/2009 | US7485429 Genetically engineered polypeptide comprising extracellular domain of integrin subunit alpha 11; marker or target of all types of cells; drugs, vaccines |
| 02/03/2009 | US7485285 Delivery of antidepressants through an inhalation route |
| 02/03/2009 | CA2390463C 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block |
| 02/03/2009 | CA2315050C Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof |
| 01/29/2009 | WO2009014127A1 Composition for prevention or treatment of disease associated with the production of autoantibody |
| 01/29/2009 | WO2009013477A1 Compounds for treating duchenne muscular dystrophy |
| 01/29/2009 | WO2009013335A1 Organic compounds |
| 01/29/2009 | WO2008149177A3 Marine lipid compositions and uses thereof |
| 01/29/2009 | WO2008138115A8 Nutritional composition comprising l-carmtme fumarate, red wine extract and saw palmetto extract for maintaining skeletal muscle androgen receptivity |
| 01/29/2009 | US20090030188 Activatable recombinant neurotoxins |
| 01/29/2009 | US20090030182 Activatable recombinant neurotoxins |
| 01/29/2009 | US20090030017 Therapeutic agent for dyskinesia |
| 01/29/2009 | US20090029929 Decoy Nucleic Acid to Synoviolin Gene Promoter |
| 01/29/2009 | US20090029912 Method of enhancing proliferation and/or survival of mesenchymal precursor cells (mpc) |
| 01/29/2009 | US20090028951 Compositions for Oral Administration of Sustained Release Glutathione, Methods for Their Production and Uses Thereof |
| 01/29/2009 | US20090028906 Process for providing a temperature-stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin in a solid form |
| 01/29/2009 | US20090028882 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/29/2009 | CA2685599A1 Compounds for treating duchenne muscular dystrophy |
| 01/28/2009 | EP2018871A1 Immunological methods to modulate myostatin in vertebrate subjects |
| 01/28/2009 | EP2018863A1 Fused heterocyclic compound and use thereof |
| 01/28/2009 | CN101352514A Chinese medicinal composition for treating myasthenia gravis and preparation method thereof |
| 01/27/2009 | US7482373 useful in the treatment of central or peripheral nervous system disorders; psychological disorders; gastrointestinal disorders |
| 01/27/2009 | US7482372 Antiinflammatory; cartilage protecting therapeutics; antiarthritic agent; N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl}-2,4-dioxo-1,3-diazaspiro[4.5]decane-6-carboxamide; 2-(2,5-dioxo-4-imidazolidinyl)-N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl)acetamide |
| 01/27/2009 | US7482026 Compositions and methods directed towards sore muscles and joints |
| 01/27/2009 | US7482024 highly dispersible mixture of drugs and dipeptides or tripeptides, in the form of liquids, aerosols or powders, administered by inhalation |
| 01/27/2009 | US7482013 Albumin fusion proteins |
| 01/27/2009 | US7482012 Streptococcus pyogenes polypeptides and corresponding DNA fragments |
| 01/27/2009 | CA2430696C Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |